Recall newer non-insulin medications for diabetes, along with risks vs
doi: 10.1161/CIRCULATIONAHA.120.050391
Semaglutide promotes feelings of fullness by triggering the GLP-1 receptors in our brains that control our appetite
Studies investigating metabolic flexibility, thermogenesis, or the interplay between insulin sensitivity and energy expenditure would benefit from survodutide's ability to modulate both glucose homeostasis and lipid metabolism through distinct receptor systems
Diabetes: A chronic health condition where the body struggles to regulate blood sugar levels, either due to insufficient insulin production or poor insulin use
Ohba Y, Mochizuki N, Yamashita S, Chan AM, Schrader JW, Hattori S, et al